894 results on '"Chien, Rong‐Nan"'
Search Results
2. A novel prognostic model to predict mortality in patients with acute-on-chronic liver failure in intensive care unit
3. Hepatitis C micro-elimination through the retrieval strategy of patients lost to follow-up
4. Comparison of clinical outcomes between aggressive and non-aggressive intravenous hydration for acute pancreatitis: a systematic review and meta-analysis
5. Long-term renal function alterations in hepatitis C patients with SVRs: Impacts of therapies and mixed cryoglobulinemia
6. Different Metabolic Associations of Hepatitis C With Colon and Rectal Cancers: A 9-Year Nationwide Population-Based Cohort Study
7. Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients
8. Evidence-Based Management of Oral Nucleos(t)ide Analogue Withdrawal in Virally Suppressed Patients with Chronic HBV Infection
9. The Role of Off-Therapy Viral Kinetics in the Timing and Severity of Flares in Hepatitis B e Antigen–Negative Patients
10. Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B
11. Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan
12. Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study
13. The Challenge of a Recall Programme From a Community-Based Hepatitis C Screening Campaign: The Effectiveness in HCV Microelimination
14. Reply: New confounders emerging with new evidence regarding reduced HCC and improved survival
15. FRI-415 Hepatitis B virus genotype and some baseline characteristics, but not race, affect HBsAg kinetics during nucleos (t)ide analogue therapy
16. FRI-426 Comparing the impact of Interferon-based and direct-acting agents therapies on HBsAg seroclearance rates in patients with hepatitis B and hepatitis co-infection
17. FRI-363-YI Association between metabolic dysfunction, severity of liver fibrosis and fibrosis progression in patients with chronic hepatitis B-an individual patient data meta-analysis
18. TOP-461-YI Retreating the off-Nuc clinical relapse with Pegylated interferon much increased HBsAg seroclearance-a propensity score matching study
19. FRI-391 Relapse incidence and severe flares in chronic hepatitis B patients with lymphoma post rituximab-based chemotherapy versus HBeAg-negative hepatitis B patients without cancer after nucleos (t)ide analogue cessation
20. Association between breast cancer and hepatitis C: A joint study of hospitalized patients and nationwide cohorts
21. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
22. Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)
23. Prognosis Comparison Between Chronic Hepatitis B Patients Receiving a Finite Course of Tenofovir and Entecavir Treatment: A Nationwide Cohort Study in Taiwan
24. Factors associated with treatment responses to pioglitazone in patients with steatotic liver disease: A 3‐year prospective cohort study.
25. Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.
26. The Challenge of a Recall Program from a Community-Based Hepatitis C Screening Campaign: The Effectiveness in HCV Microelimination.
27. Hepatitis C-associated late-onset schizophrenia: a nationwide, population-based cohort study
28. Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
29. Higher end‐of‐treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg‐negative chronic hepatitis B patients stopping antivirals
30. Evolutionary relationship between antimitochondrial antibody positivity and primary biliary cholangitis in Taiwan: a 16-year hospital cohort study
31. The epidemiological profile of chronic hepatitis C with advanced hepatic fibrosis regarding virus genotype in Taiwan: A nationwide study
32. Interactive Impacts from Hepatitis C Virus Infection and Mixed Cryoglobulinemia on Complement Levels
33. Correction: Comparing Predictability of Non‑invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients
34. Unsolved issues in treatment for grey zone chronic hepatitis B patients
35. Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes.
36. Hepatitis Flares Are Associated With Better Outcomes Than No Flare in Patients With Decompensated Cirrhosis and Chronic Hepatitis B Virus Infection
37. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
38. One-year efficacy of tenofovir alafenamide in patients with chronic hepatitis B: An observational study
39. Reply: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game?
40. Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype
41. Reply: Cautious interpretation of the association between finite treatment and better prognosis in initially HBeAg-negative hepatitis B patients with cirrhosis
42. Comparing Three Profoundly Influential Prognostic Scores in Cirrhotic Patients with Acute-on-Chronic-Liver Failure Admitted to the ICU: Prediction of One-Month Mortality—A Retrospective Cohort Study
43. Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B
44. Hepatitis B virus X gene mutants emerge during antiviral therapy and increase cccDNA levels to compensate for replication suppression
45. Renal function trajectories in hepatitis C infection: differences between renal healthy and chronic kidney disease individuals
46. Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients
47. Critical role of triglycerides for adiponectin levels in hepatitis C: a joint study of human and HCV core transgenic mice
48. A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy
49. Hepatocellular carcinoma reduced, HBsAg loss increased, and survival improved after finite therapy in hepatitis B patients with cirrhosis.
50. Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.